Standalone figures
| Ratio | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Margins | |||
| Gross margin % | 15.4% | 13.7% | 19.8% |
| EBITDA margin % | 7.3% | 5.9% | 11.5% |
Standalone figures
| Ratio | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Margins | |||
| Gross margin % | 15.4% | 13.7% | 19.8% |
| EBITDA margin % | 7.3% | 5.9% | 11.5% |
| EBIT margin % |
| 6.2% |
| 4.9% |
| 10.7% |
| PAT margin % | 3.6% | 2.6% | 6.9% |
| Working capital | |||
| Receivable days | 4 | 6 | 14 |
| Inventory days | 201 | 220 | 280 |
| Payable days | 16 | 10 | 33 |
| NWC days | 189 | 217 | 262 |
| Leverage | |||
| Current ratio | 1.56 | 1.7 | 1.56 |
| Debt to EBITDA | 3.92 | 4.75 | 2.37 |
| Debt to equity | 1.09 | 0.89 | 0.9 |
| Interest coverage | 3.4 | 2.7 | 4.9 |
| Asset turnover | 1.41 | 1.32 | 1.21 |
| Return ratios | |||
| Return on assets % | 5.1% | 3.5% | 8.4% |
| Return on capital employed % | 22.5% | 18.6% | 38% |
| Return on equity % | 13.7% | 8.3% | 22.9% |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.